...
首页> 外文期刊>Integrated Pharmacy Research and Practice >Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission
【24h】

Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission

机译:医院范围内的药物和解程序:错误识别,成本效益和检测入院时的高风险个人

获取原文
           

摘要

Background: Medication reconciliation (MR) on admission has potential to reduce negative patient outcomes. The objectives of this prospective observational study were to 1) measure the impact a hospital-wide MR program has on home medication error identification at hospital admission, 2) demonstrate cost-effectiveness of this program, and 3) identify risk factors placing individual patients at higher risk for medication discrepancies. Methods: Technicians obtained medication histories on adult patients admitted to the hospital that managed their own medications. Frequency and type of medication errors were recorded. Cost avoidance estimations were determined based on expected adverse drug event rates. Logistic regression analysis was used to test for associations between medication errors and patient characteristics. Results were considered significant when p-value was less than 0.05. Results: The study included 817 patients. Technicians recorded a mean of 6.1 medication discrepancies per patient (SD ± 0.4) and took 28.5 minutes (SD ± 1.2 minutes) to complete a medication history. Omission, commission, and dosing/frequency errors occurred in 82%, 59%, and 50% of medication histories, respectively. We estimated cost avoidance of $210.33 per patient with this program. Female gender, age, and high alert/risk medication use were linked to an increase in the likelihood of occurrence of a medication discrepancy. Conclusion: This study validated the ability of a pharmacy technician to identify errors, demonstrated economic cost-effectiveness, provided new data on time to obtain a BPMH, and further identified factors that contribute to the occurrence of medication discrepancies. Potentially harmful medication discrepancies were identified frequently on admission. With further research, it may be possible to identify those at highest risk for home medication discrepancies upon admission.
机译:背景:入学中的药物和解(MR)有可能降低消极患者结果。这个潜在观察研究的目标为1)衡量医院 - 宽的先生计划对医院录取的影响,2)表现出该计划的成本效益,3)识别将个体患者放置的危险因素药物差异的风险较高。方法:技术人员对成人患者的药物历史,患者录取为医院管理自己的药物。记录了药物误差的频率和类型。成本避免估计是根据预期的不良药物事件率确定的。物流回归分析用于测试药物误差和患者特征之间的关联。当p值小于0.05时,结果被认为是显着的。结果:该研究包括817名患者。技术人员记录了每位患者6.1药物差异的平均值(SD±0.4),并服用28.5分钟(SD±1.2分钟)来完成药物历史。遗漏,委托和计量/频率误差分别发生在82%,59%和50%的药物历史中。我们估计每位患者的成本避免210.33美元。女性性别,年龄和高警报/风险药物使用与药物差异发生的可能性的增加有关。结论:本研究验证了药房技术人员识别误差的能力,表现出经济成本效益,提供了新的数据,提出了新的数据,以获得BPMH,并进一步确定有助于发生药物差异的因素。潜在有害的药物差异差异在入场时经常确定。通过进一步研究,可以在入院时识别家庭药物差异的最高风险。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号